Tusk Therapeutics to be acquired by Roche   Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018:  Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...

Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018 Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018 ~ A first-in-class anti-CD25 Treg depleting antibody which enables Teff responses for optimal anti-cancer...

Tusk Therapeutics to Present Data at AACR Annual Meeting 2018 Tusk Therapeutics to Present Data at AACR Annual Meeting 2018 London and Stevenage, UK - 28 March 2018:  Tusk Therapeutics, an immuno-oncology company focused on developing immune-modulating...